Page last updated: 2024-10-27

fluorouracil and Enterobacteriaceae Infections

fluorouracil has been researched along with Enterobacteriaceae Infections in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Enterobacteriaceae Infections: Infections with bacteria of the family ENTEROBACTERIACEAE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishitsuka, H1
Umeda, Y1
Nakamura, J1
Yagi, Y1
Hirakata, Y1
Furuya, N1
Matsumoto, T1
Tateda, K1
Yamaguchi, K1

Other Studies

2 other studies available for fluorouracil and Enterobacteriaceae Infections

ArticleYear
Protective activity of thymosin against opportunistic infections in animal models.
    Cancer immunology, immunotherapy : CII, 1983, Volume: 14, Issue:3

    Topics: Animals; Candida albicans; Candidiasis; Drug Administration Schedule; Enterobacteriaceae Infections;

1983
Influence of various immunosuppressive agents on the occurrence of endogenous bacteraemia in mice.
    Journal of medical microbiology, 1995, Volume: 42, Issue:3

    Topics: Animals; Bacteremia; Cisplatin; Cyclophosphamide; Enterobacteriaceae Infections; Fluorouracil; Immun

1995